Innospec Inc. reported $1.84B of revenue over the trailing twelve months, +2.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.84B (to Q2 2026). Net income: $122M, trailing twelve months to Q2 2026. Free cash flow: $69M, trailing twelve months to Q2 2026. Operating margin: 6.9%, trailing twelve months to Q2 2026.

IOSPInnospec Inc.

Basic Materials

$95.59+23% 1Y

$95.59

$65.1252 weeks$98.69

IOSP as reported

Innospec Inc. reported $1.84B of revenue over the trailing twelve months, +2.9% on the year before. 11 reported series are charted on this page, each one as filed.

$1.84B

Revenue, trailing twelve months · to Q2 2026 · +2.9% against the twelve months before

Net income: $122M
Net income · +530% year on year · trailing twelve months to Q2 2026
Free cash flow: $69M
Free cash flow · −29% year on year · trailing twelve months to Q2 2026
Operating margin: 6.9%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for IOSP, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.84B	+2.9%	Q2 2026
Net income	$122M	+530%	Q2 2026
EPS	$4.90	+528%	Q2 2026
Gross margin	27%	n/a	Q2 2026
Operating margin	6.9%	n/a	Q2 2026
Net margin	6.6%	n/a	Q2 2026
ROE	6.6%	n/a	Q2 2026
ROA	4.8%	n/a	Q2 2026
ROIC	−4.4%	n/a	Q1 2021 · 21 quarters behind
Free cash flow	$69M	−29%	Q2 2026
P/E	19.5	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.